In the News


SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential

ScienceDirect | September 22, 2020

How initial CHIRP participant samples are already being used to understand the immunology underlying the host response against SARS-CoV-2 virus. Here, samples from our first CHIRP participants showed that recovering COVID+ can mount robust immune cell responses (cells called “T” cells) against the virus. This suggests an important role for T cells in viral clearance and ways in which T cell function can be used to diagnose and potentially target SARS-CoV-2 virus.

Read Full Article


The Mystery of Why Some People Don’t Get Sick, Despite Coronavirus Infection

Mercury News | August 3, 2020

How CHIRP is enrolling patients with a range of COVID-19 disease severity in order to identify protective host genetic and immune responses that can be leveraged for future treatment strategies.

Read Full Article

ucsf magazine

How Infection Sets In

UCSF Magazine | Summer 2020

How CHIRP plans to contribute to UCSF’s efforts to combat COVID-19.

Read Full Article

Colleen cropped

The Curious Case of the SF Doctor Who's Been Coronavirus-Positive Nearly 90 Days and Counting

SF Chronicle | May 30, 2020

How CHIRP plans to study unique individuals like Coleen to better understand how the host responds to SARS-CoV-2 virus.

Read Full Article